Phaseline

Companies › IlDong Pharmaceutical

IlDong Pharmaceutical: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Other.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
ID110521156–Phase 1Healthy Adult Subjects–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06635226ID110521156Phase 1Healthy Adult SubjectsOtherJun 2025

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.